A postal questionnaire inquiring into the presence of respiratory symptoms was sent to 3698 children aged 7 and 8 years. Those reporting either cough or wheeze were randomised, and a sample invited to attend for skin testing. A total of 192 symptomatic children, half of whom were atopic and half non-atopic, were randomly selected to enter the study.
its relationship to atopy was examined by comparing the percentage of members of each symptom group demonstrating bronchial hyper-responsiveness and the number of occasions on which they did so, and by comparison of minimum and median PD20 values. The range of bronchial responsiveness shown during the study period by each child was expressed as doubling doses of methacholine and compared between symptom groups.
Atopy and wheeze were both independently associated with an increased prevalence and greater degree of bronchial hyper-responsiveness when compared with non-atopy and cough respectively, all differences being significant at the 0-001 level. Thirty three per cent of subjects demonstrated a range of methacholine responsiveness of >4 and 13-4% of >6 doubling doses during one year.
Respiratory symptoms are common in childhood with as many as 25% of children aged [7] [8] [9] [10] years being troubled by recurrent episodes of cough and wheeze.' However, a diagnosis of asthma is made in less than half this number,2 despite the recent appreciation of asthma as a range of diseases with differing clinical mani- festations. This under diagnosis leads to under treatment and increased respiratory morbidity.
Many, but by no means all, asthmatic subjects demonstrate bronchial hyper-responsiveness (BHR),3 as do a proportion of adult subjects suffering from respiratory symptoms in the absence of diagnosed asthma.4 However, because of its lack of specificity and low sensitivity for asthma, non-specific bronchial challenge has not proved to be a diagnostic test as was once hoped.S-8 Measurements of bronchial responsiveness may, however, serve as a useful laboratory tool, and as BHR may be potentially of importance in the pathogenesis of chronic obstructive pulmonary disease in adult life,9 this phenomenon merits the fullest investigation.
Much of the current knowledge regarding the relationship between bronchial responsiveness and other factors such as symptoms, measurements of airflow obstruction, and atopic status has been derived from studies that were cross sectional in nature, and assumptions often made on the basis of single measurements of reactivity. Whereas (2) In the last 12 months, has your child seemed to cough more (or to get more coughs) than other children? (3) In the last 12 months, has your child woken at night with coughing for 3 or more nights in a row (apart from during the first 5 days of a cold)?
The positive responders were identified. For a child to be designated as having cough, it was necessary for them to have answered in the affirmative to one or both ofthe cough questions, but to have answered in the negative to that on wheeze. For a child to be designated as having wheeze, they must have given a positive reply to the wheeze question, and may have answered in the affirmative or the negative to the cough questions.
A random sample of children from each symptom group were tested by skin prick to 10 activations, the initial content being 1 ml of 0-9% sodium chloride. This procedure was repeated nine times. Variability in the output of the nebulisers was determined by the analysis of variance, in order to derive both the within-day and between-day coefficients of variation for each nebuliser. The eight nebulisers with the smallest coefficients of variation were subsequently used in the challenges. The within-day and between-day coefficients of variation for these nebulisers are shown in table 1 . Solutions of methacholine, prepared in 0 9% sodium chloride, were made up for each nebuliser taking into account the mean output of each instrument such that the first delivered exacdy 0-025 ,umol, the second 0-1 FImol, the third 0 4 ,umol, and the fourth 0-8 ,umol per puff. A fifth nebuliser was used to administer saline.
At the start of each visit, baseline FEV1 manoeuvres were performed to obtain two technically acceptable recordings within 100 ml. If the higher of these exceeded 60% of the predicted value for the child's height and age the challenge proceeded. The children were instructed in the use of the nebulisers. Once the investigator was satisfied that the child could perform the procedure correctly, two puffs of 0-9% sodium chloride were administered. In order to study the temporal relationship between the provocation dose required to cause a 20% fall in FEV1 (PD20), PEF, and symptoms, the data for each of the 192 subjects commencing the study were plotted graphically. An example is shown in fig 1. Though the information gained from examination of these charts was necessarily subjective, it proved invaluable in directing further analysis, as manipulation of the data was difficult owing to its size (>800 000 data points).
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For each of the four symptom groups, the and checked for following parameters were calculated: (1) After exclusion of the first test, each child was subjected to 11-15 (median 13) methacholine challenges. Using the analysis of Bland and Altman, the coefficient of repeatability, calculated on data from the 14 children who performed methacholine challenge on two consecutive days, was 1-3 doubling doses (table 3) . The prevalence of BHR in each symptom group is shown in table 2. Prevalence figures are also given for all atopic subjects and non-atopic subjects, and for those with wheeze and cough collectively. BHR was positively associated with both atopy and wheeze (Mann-Whitney U test, p<OOOl), and no interaction between these factors was demonstrated. Despite significant symptoms, only 7-7% of the non-atopic subjects with cough demonstrated BHR on one or more occasions during the study period. No of times hyper-responsive Figure 2 Frequency distribution ofthe number oftimes (maximum 12) that subjects in each ofthefour symptom groups demonstrated bronchial hyper-responsiveness to methacholine.
Discussion
This study demonstrates a clear relationship between BHR and the presence of both atopy and the symptom of wheeze in a large group of symptomatic subjects in whom bronchial responsiveness was measured repeatedly over the course of one year. Bronchial responsiveness was shown to vary considerably in individuals over this time, almost 33% of subjects demonstrating >4 doubling dose variation in PD20, although short term repeatability was good.
The children entered into this study were heterogeneous with regard to both symptom type and symptom severity. Many young children experience recurrent cough in the absence of wheezing, and the significance of this troublesome symptom is not clearly understoo although it is often included as a symptom childhood asthma. Thus we were eager to stu( subjects with cough as a sole symptom. selected our subjects using a parent administer( questionnaire, which inquired into the preseni in the past 12 months of specific symptoms. V were thus able not only to avoid the predete mination of what was, or was not, asthma, b also to include in the study children wi symptoms ranging in severity from mild frankly asthmatic. In this study, short term repeatability of tl challenge procedure was found to be within 1 doubling doses ofmethacholine, which compari favourably with the findings of other worke using the method of Yan.' 13 It was essenti that, if inferences were to be made from oi findings on the long term variability of meth choline responsiveness, great care was taken ensure that the techniques used for challenj testing remained as repeatable as possible throughout the study period. Each child was tested by the same investigator at each visit, unless that investigator was unavailable due to sickness, when she was replaced by the principal investigator. Each child was tested at the same time of day on each occasion in order to exclude any effect of diurnal variation, and in the same room, to minimise environmental influences. Antiasthma medication was withheld as described, and the children were rested for 10 minutes before testing. Fresh solutions of methacholine were prepared weekly, in concentrations calculated specifically for each nebuliser and the investigator using it.
Because of the nature of the study, we obtained at least 12 PD20 values on all but 11 subjects and our analysis could thus be based on data collected over a 12 month period. This had the benefit of lessening the influence of the factors that can affect individual measurements of bronchial responsiveness and therefore strengthening the analyses. In spite of this, the relationship between BHR, atopy, and respiratory symptoms remained complex. Eleven per cent of those subjects with both atopy and wheeze never, at any time, demonstrated BHR, and for those demonstrating either atopy or wheeze this proportion rose to 64% and 69% respectively. These findings confirm those of Pattemore et Over prolonged periods of time, bronchial responsiveness has been described as being a stable phenomenon.27 However, the findings of the present study would seem to support those of Josephs et al, who found that airways responsiveness in the clinical setting can vary considerably. 3 In this study, PD20 was found to vary by up to nine doubling doses ofmethacholine in individual subjects over a 12 month period, one third of subjects demonstrating a variation of >4 doubling doses. As many subjects demonstrated levels of bronchial responsiveness near or above the upper limit measured, and indeed, 48 (25-8%) children were never hyperresponsive, it would have been possible for only the most responsive subjects to exhibit the maximum degrees of variability in PD20, and thus these figures are likely to underestimate the variability in PD20 that would be found if testing were to be performed over a greater range of methacholine concentrations.
As in the longitudinal study performed by Josephs et al,'3 which included as subjects both children and adults, visual examination of the charted data failed to demonstrate a temporal relationship between PD20 and the state of asthma described by level of PEF, day to day and diurnal variability in PEF, and symptom score. It would seem that while a broad relationship does exist between both atopy and wheeze and BHR, in individuals levels of bronchial responsiveness can vary greatly, and at any particular moment in time there is little correlation between PD20 methacholine and the severity of asthma, whether measured in terms of symptoms or changes in PEF.8 Due to the problems posed by the large number of subjects participating in this study and their clinical heterogeneity, combined with the lack of evidence of any relationship yielded by visual inspection of the charted data, we did not analyse the data from the complete cohort for temporal relationships between symptoms and changes in PEF and bronchial responsiveness. However, such analyses on selected children will form the basis of a further publication.
Although measurement of bronchial responsiveness has useful applications as a research tool, and may be able to predict those subjects at risk of accelerated decline in lung function,28 its lack of correlation with the clinical state of asthma and its variability over time make it less suitable for use as a test for diagnosis, assessment of treatment requirement and determination of prognosis, especially in children. Already, the small number of longitudinal studies in existence that incorporate responsiveness measurements have altered our views on the relevance of BHR to airways disease. Further studies, particularly in the early years of life, are greatly needed to establish the significance of BHR in relation to the range of diseases of childhood which are currently encompassed under the single diagnostic label of asthma.
